Lancet 2001,357(9262):1076–1079.PubMedCrossRef 21. Niers L, Martin R, Rijkers G, Sengers F, Timmerman H, van Uden N, Smidt H, Kimpen J, Hoekstra M: The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy 2009,64(9):1349–1358.PubMedCrossRef 22. Kukkonen
K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M: Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol 2007,119(1):192–198.PubMedCrossRef 23. Wickens K, Black P, Stanley T, Mitchell E, Fitzharris P, Tannock G, Purdie G, Crane J: Probiotic study group. GSK2126458 manufacturer A differential effect of 2 probiotics in the prevention of eczema and atopy: a double-blind, randomized, placebo-controlled trial. J Allergy Clin Immunol 2008,122(4):788–794.PubMedCrossRef 24. Adlerberth I, Strachan D, Matricardi P, Ahrné S, Orfei L, selleck chemicals Aberg N, Perkin MR, Tripodi S, Hesselmar B, Saalman R, Coates AR, Bonanno CL, Panetta V, Wold AE: Gut microbiota and development
of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol 2007,120(2):343–350.PubMedCrossRef 25. Kopp M, Hennemuth I, Heinzmann A, Urbanek R: Randomized, double-blind, placebo-controlled trial of probiotics for primary Dynein prevention: no clinical effects of Lactobacillus GG supplementation. Pediatrics 2008,121(4):e850–6.PubMedCrossRef 26. Taylor A, Dunstan J, Prescott S: Probiotic supplementation for the first 6 months of life fails to reduce the risk of atopic dermatitis and increases the risk of allergen sensitization
in high-risk children: a randomized controlled trial. J Allergy Clin Immunol 2007,119(1):184–191.PubMedCrossRef 27. Zoetendal EG, Rajilic-Stojanovic M, de Vos WM: High-throughput diversity and functionality analysis of the gastrointestinal tract microbiota. Gut 2008,57(11):1605–1615.PubMedCrossRef 28. Rajiliç-Stojanoviç M, Heilig H, Molenaar D, Kajander K, Smidt H, de Vos W: Development and application of the Human Intestinal Tract Chip (HITChip), a phylogenetic microarray: absence of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 2009, 11:1736–1743.PubMedCrossRef 29. Palmer C, Bik EM, Digiulio DB, Relman DA, Brown PO: Development of the human infant intestinal microbiota. PLoS One 2007,5(7):e177. 30. Paliy O, Kenche H, Abernathy F, Michail S: High-throughput quantitative analysis of the human intestinal microbiota with a phylogenetic microarray. Appl Environ Microbiol 2009,75(11):3572–3579.PubMedCrossRef 31. Yu Z, Morrison M: Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 2004,36(5):808–812.PubMed 32.